Clinical trial
Patient, Physician And Nurse Factors Associated With Entry Onto Clinical Trials And Completion Of Treatment For Women With Primary Or Recurrent Invasive Cancer Of The Uterine Corpus Or Uterine Cervix, All Stages
NCT01098630 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient, Physician And Nurse Factors Associated With Entry Onto Clinical Trials And Completion Of Treatment For Women With Primary Or Recurrent Invasive Cancer Of The Uterine Corpus Or Uterine Cervix, All Stages
- Lead sponsor
- Gynecologic Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- January 27, 2018
- Enrollment
- 778 (actual)
- Sites
- 167
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent cervical carcinoma, recurrent uterine corpus carcinoma, recurrent uterine corpus sarcoma, stage i uterine corpus cancer, stage i uterine sarcoma, stage ia cervical cancer, stage ib cervical cancer, stage ii uterine corpus cancer, stage ii uterine sarcoma, stage iia cervical cancer, stage iib cervical cancer, stage iii cervical cancer, stage iii uterine corpus cancer, stage iii uterine sarcoma, stage iv uterine corpus cancer, stage iv uterine sarcoma, stage iva cervical cancer, stage ivb cervical cancer